Laura Codarri Deak

8PUBLICATIONS

87CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 19, 2026

First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumors.

|Jun 12, 2026

Tobemstomig, a novel bispecific antibody, preferentially blocks PD-1 and LAG-3 on CD8 TILs to expand stem-like T-cells for sustained tumor control.

|May 28, 2026

FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.

|Apr 07, 2026

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1-LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma.

Elena Garralda, Christoph Markert, Victor Moreno

|Nov 14, 2025

Advanced cytokine-based immunotherapies: targeted cis-delivery strategies for enhanced anti-tumor efficacy and reduced toxicity.

Laurène Pousse, Amrita Manchala, Christian Klein

|Sep 17, 2025

PD-1-targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer.

Irene Fusi, Clara Serger, Petra Herzig

Pageof 2

Frequent Collaborators

Christian Klein

Pablo Umaña

Tamara Hüsser

Emilio Yangüez

Masao Hashimoto

Klas Hatje

Dae Ho Lee

Kristoffer Staal Rohrberg

2 joint publications

Merlind Mücke

2 joint publications

Victor Moreno

Frequent Collaborators

Christian Klein

Pablo Umaña

Tamara Hüsser

Emilio Yangüez